IFI-M · PCK Tri-Axis Dominant-Primary Series

Specimen SS-F-M3-01295 // MULTI-AXIS · IFI-M

PCK Tri-Axis Dominant-Primary Series IV-NP

Brassica nigra

Black Mustard

Tier IVPCK Tri-Axis Dominant-Primary Series

Target Trait

2.38×

fold-change

Sharp-dominant tri-axis C+K modulated fold-change

Technical Specifications

SKU

SS-F-M3-01295

Genomic Edits

11

GC Content

47.3%

Construct Length

6,133 bp

Promoter System

Lipid nanoparticle / Ubiquitin

Expression System

Nanoparticle delivery

Host Strain

LNP-mediated

Receptor Target

TRPA1 + TRPM8 + CaSR

IFI Score

238

Pathway Edits

  • TRPA1 pathway primary gene cluster for sharp (IFI-P) tri-axis component
  • TRPM8 pathway primary gene cluster for cooling (IFI-C) tri-axis component
  • CaSR pathway primary gene cluster for kokumi (IFI-K) tri-axis component
  • Tri-axis metabolic flux partitioning hub for concurrent PCK pathway operation
  • Cross-pathway regulatory circuit for sharp-dominant PCK triple-axis expression
  • Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPA1, TRPM8, and CaSR pathways simultaneously engineeredSharp-dominant tri-axis expression strategy (PCK) with cross-pathway flux managementLNP-mediated delivery of triple-axis mRNA panel for transient expression profiling

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier IV PCK triple-axis construct for advanced multi-modal sensory architecture combining sharp, cooling, and kokumi axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$4249 · Tier IV License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities